DFQTX
Price
$34.54
Change
+$0.13 (+0.38%)
Updated
Apr 17 closing price
Net Assets
29.19B
VITSX
Price
$125.99
Change
+$0.29 (+0.23%)
Updated
Apr 17 closing price
Net Assets
1.7T
Ad is loading...

DFQTX vs VITSX

Header iconDFQTX vs VITSX Comparison
Open Charts DFQTX vs VITSXBanner chart's image
DFA US Core Equity 2 I
Price$34.54
Change+$0.13 (+0.38%)
VolumeN/A
Net Assets29.19B
Vanguard Total Stock Market Idx I
Price$125.99
Change+$0.29 (+0.23%)
VolumeN/A
Net Assets1.7T
DFQTX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DFQTX vs. VITSX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFQTX is a Buy and VITSX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.7T vs. DFQTX (29.2B). VITSX pays higher dividends than DFQTX: VITSX (1.36) vs DFQTX (1.23). DFQTX was incepted earlier than VITSX: DFQTX (20 years) vs VITSX (28 years). DFQTX (0.19) is less costly to investors than VITSX (0.03). DFQTX is a more actively managed with annual turnover of: 8.00 vs. VITSX (2.00). DFQTX has a lower initial minimum investment than VITSX: DFQTX (0) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 4.35 vs. DFQTX (3.63). DFQTX return over 5 years is better than : 86.38 vs. VITSX (80.96).
DFQTXVITSXDFQTX / VITSX
Total Expense Ratio0.180.03600%
Annual Report Gross Expense Ratio0.190.03633%
Fund Existence20 years28 years-
Gain YTD-10.216-10.85494%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets29.2B1.7T2%
Annual Yield % from dividends1.231.3690%
Returns for 1 year3.634.3583%
Returns for 3 years15.7817.5590%
Returns for 5 years86.3880.96107%
Returns for 10 years100.17146.1569%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XTNT0.450.05
+13.67%
Xtant Medical Holdings
PMCB1.190.04
+3.48%
PharmaCyte Biotech
SWK57.210.40
+0.70%
Stanley Black & Decker
FLYW8.880.05
+0.57%
Flywire Corp
HCKT25.86-0.17
-0.65%
Hackett Group